Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle-aged individuals with metabolic dysfunction.
Alessandro MantovaniSerena PelusiSara MargaritaFrancesco MalvestitiMichela Dell'AlmaCristiana BiancoLuisa RonzoniDaniele PratiGiovanni TargherLuca Vittorio ValentiPublished in: Alimentary pharmacology & therapeutics (2023)
levels in middle-aged individuals with metabolic dysfunction. This association was independent of established risk factors, ethnicity and genetic predisposition to CKD. PNPLA3 p.I148M silencing may protect against kidney damage progression in carriers.